Indian doctors urge vigilance as COVID-19 cases rise
The new spread of the virus that a few years ago brought the world to a standstill has been linked to JN.1, a highly transmissible subvariant of the Omicron strain of the COVID-19 virus. It emerged in late 2023 and spread globally through early 2024, becoming one of the dominant variants in many countries.
As COVID-19 cases surged in Southeast and East Asia, India's health authorities held an expert meeting on Monday.
It concluded that 'the current COVID-19 situation in India remains under control,' as the Ministry of Health reported only 257 active COVID-19 cases nationwide and 'almost all of these cases are mild, with no hospitalization required,' officials told the Press Trust of India.
Kerala has recorded the highest infection numbers, followed by Maharashtra, and Tamil Nadu.
The actual number of cases, however, was likely to be much higher, as coronavirus testing is not being conducted regularly.
'What we have is called multiplex PCR, which tests for multiple organisms, including COVID. That's why we are catching these patients,' Dr. Atul Kakar, of Internal Medicine at the Sir Ganga Ram Hospital in Delhi, told Arab News.
'All these cases which we have seen, they are like a normal viral infection itself … We need to be vigilant, but it's not to create panic.'
In 2021, India was one of the worst-hit countries during the COVID-19 pandemic. At its peak, health authorities recorded over 400,000 new cases per day.
Hospitals across many states were overwhelmed with patients and faced severe shortages of oxygen supplies, hospital beds, ventilators, and critical medicines.
The World Health Organization estimates that 4.7 million deaths in India were directly and indirectly related to COVID-19.
While the prevalent virus variant behind the current spike in Asia spreads quickly, the type of infection seen in India appears to be showing that it is less severe than the one that wreaked havoc in 2021.
'Fortunately, it is mostly an upper respiratory infection. Only people with immunodeficiency, severe comorbid disease, old age, on steroids, on cancer therapy will have more severe disease,' Dr. Jacob John, renowned virologist and retired professor at the Christian Medical College, Vellore, told Arab News.
'We always have to be alert about all respiratory infections ... particularly senior citizens or anybody with any chronic lung, chronic heart, chronic kidney diseases, and on steroid therapy, immunosuppressed. They should all wear a good mask.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Arabiya
4 days ago
- Al Arabiya
Biocon aims to launch generic Wegovy drug for weight loss in India, Canada within two year
Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years, a top executive told Reuters, seeking to tap into a market that is estimated to grow to $150 billion globally by the early 2030s. The push comes after Danish drugmaker Novo Nordisk and US-based rival Eli Lilly saw skyrocketing demand for their obesity drugs Wegovy and Zepbound. Biopharmaceutical company Biocon plans to submit a request for approval to India's drug regulator by the end of 2026 and potentially launch in 2027 through a partner, CEO Siddharth Mittal said in an email interview on Tuesday. The company, which also makes insulin products, expects to complete late-stage trials within the next 12 to 18 months, he added. 'Biocon is actively progressing with filings for semaglutide in Canada as well as many other emerging markets,' Mittal said. Semaglutide is the active ingredient in Novo's drugs Ozempic and Wegovy, used for diabetes and weight-loss management. Indian generic drugmakers, including Dr Reddy's and Cipla, have been racing to produce cheaper versions of Wegovy when semaglutide goes off patent in 2026. Novo launched Wegovy in India for diabetes and weight-loss management in June after Lilly's Mounjaro sales doubled within a few months following its launch in the south Asian country. Biocon plans to file with Canadian regulatory authorities this quarter for generic versions of Ozempic and later this year for Wegovy versions. 'Subject to approval, we could look at a market launch in late 2026 or early 2027,' he said. Canada has not approved any such therapies yet, the company said. In addition to Canada, Biocon will focus on large emerging markets such as Brazil and Mexico in Latin America, Malaysia and Hong Kong, countries in the Middle East, as well as Australia, and New Zealand to launch obesity drugs, according to the CEO. In markets where Biocon does not have a direct presence, it is seeking local partnerships to commercialize its products, Mittal said.
Saudi Gazette
5 days ago
- Saudi Gazette
Shoura council urges culture ministry to expand music and cinema programs, calls for arts school independence
Saudi Gazette report RIYADH — The Shoura Council on Monday called on the Ministry of Culture to broaden its academic programs in music, cinema, theater, and performing arts, while also working toward full financial and administrative independence for its cultural commissions to ensure their sustainability and effectiveness. During its 39th regular session, the council urged the ministry's Museums Commission to upgrade exhibits at the National Museum to reflect recent archaeological discoveries, and called for an annual publishing plan for Saudi literary works. It also encouraged coordination with the Ministry of Education to revive school theater programs and stimulate domestic theatrical activity. The council issued several other recommendations across government sectors. It asked the National Center for Mental Health Promotion to establish a unified national framework to accredit public and private mental health providers and monitor psychological consultation apps, and to support school health awareness efforts in partnership with the Ministry of Health. Regarding the National Institute for Educational Professional Development, the council proposed recognizing teacher preparation programs in employment standards and called for the formation of professional learning communities in also pressed the General Authority for Competition to implement preemptive deterrents against anti-competitive practices and urged faster integration with the government's 'Etimad' it called on the General Authority for Statistics to enhance the release of economic and development data and coordinate to boost Saudi talent placement in global council advocated for attracting and localizing Saudi capital abroad to align with domestic investment opportunities, and advised resolving overlapping jurisdictions to improve the investment climate ahead of Expo sports, the council asked the Sports Boulevard Foundation to comply with Cabinet reporting guidelines and improve services at its also reviewed the Ministry of Health's annual report, recommending equal healthcare access, better availability of essential medicines, and direct user feedback through the 'Sehhaty' emphasized improving capabilities at specialty hospitals in remote areas and incentivizing skilled also proposed new regulatory frameworks for healthcare practitioners creating media content and stricter oversight of health content on social suggestions included enabling remote consultations with central hospitals, and developing medical wellness resorts to utilize Saudi Arabia's natural assets for sustainable economic and healthcare education and investment, the council called on the Ministry of Industry and Mineral Resources to evolve regional incentive frameworks and align with local sectoral also urged the Ministry of Sports to fast-track club privatization, expand school and university sports, and foster talent pipelines tied to professional stressed the need for greater private investment in sports, enhanced sports medicine, and a professional media ecosystem to support Saudi Arabia's global sporting called for a youth-focused strategy for community and competitive sports, and for nurturing talent across all age categories to elevate Saudi athletes on the global stage.
Arab News
12-07-2025
- Arab News
US ends case against doctor over alleged Covid vaccine scheme
WASHINGTON: US Attorney General Pam Bondi said Saturday she had ordered charges to be dropped against a doctor accused of destroying Covid-19 jabs and issuing fake vaccination certificates. The abrupt halt to proceedings comes just days after the trial commenced, and is the latest boost to the vaccine-skeptic movement from President Donald Trump's administration. Michael Kirk Moore, a plastic surgeon in the western state of Utah, was charged by the Department of Justice in 2023 alongside his clinic and three others for 'running a scheme' to defraud the government. He was accused of destroying or disposing of over $28,000 worth of government-provided Covid vaccines and handing out at least 1,937 false vaccine record cards in exchange for payment. Moore, who faced decades behind bars, was also accused of administering a saline solution to children — at the behest of their parents — so that they would think they had been vaccinated against Covid. Moore's trial began this week at a federal court in Salt Lake City. But on Tuesday, Republican lawmaker Marjorie Taylor Greene, one of Trump's most vocal hard-right supporters, said she had written to Bondi calling for charges against Moore to be dropped. 'Dr. Moore gave his patients a choice when the federal government refused to do so. He did not deserve the years in prison he was facing. It ends today,' Bondi wrote on X. Bondi's decision also notably comes as she faces fire from right-wing activists over her handling of a probe into the late financier Jeffrey Epstein. She thanked Greene and Utah Senator Mike Lee, another hard-right lawmaker, for their advocacy for dropping charges against Moore. The Covid-19 pandemic sparked fierce political division in the US between those who supported lockdowns and vaccination drives, and those who considered the measures as restrictions on freedom. Trump, himself vaccinated against Covid-19, has appointed as his Health Secretary Robert F. Kennedy Jr., who has initiated an overhaul of American vaccine policy. Kennedy said Moore 'deserves a medal for his courage and commitment to healing,' in an X post in April. At the end of May, Kennedy announced that federal authorities would no longer recommend Covid-19 jabs for children and pregnant women, prompting accusations from medical groups that he was taking away parents' ability to opt for vaccinations. Kennedy has been accused of spreading vaccine misinformation, including about the measles vaccine, even as the US grapples with its worst measles epidemic in 30 years.
